citrulline has been researched along with Mouth Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buas, MF; Chen, C; Djukovic, D; Gu, H; Lohavanichbutr, P; Nagana Gowda, GA; Raftery, D; Wang, P; Zhang, Y | 1 |
| Brennan, PA; Langdon, JD; Palacios-Callender, M; Tant, S; Umar, T | 1 |
2 other study(ies) available for citrulline and Mouth Neoplasms
| Article | Year |
|---|---|
Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chromatography, Liquid; Citrulline; Early Detection of Cancer; Female; Glycine; Humans; Linear Models; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Ornithine; Oropharyngeal Neoplasms; Proline; Saliva; Tandem Mass Spectrometry | 2018 |
Expression of type 2 nitric oxide synthase and p21 in oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Carcinoma, Squamous Cell; Citrulline; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Female; Humans; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Statistics, Nonparametric | 2002 |